Selected speakers
- Markus Zettl, Boehringer Ingelheim, DE
Topic: Biologics - immunomodulatory antibody therapeutics
- Jeroen van Bokhoven, ETH Zurich, PSI Villigen, CH
Topic: EXAFS – a Powerful Tool for Exploring Materials
- Andrzej Marek Brzozowski, Department of Chemistry University
of York, UK
Topic: Structural endocrinology and medicinal chemistry
- Richard Mackman, Gilead Sciences, Foster City, USA
Topic: Discovery and development of novel virostatics
- Peter Sebo, Institute of Microbiology, ASCR Prague, CZ
Topic: Next generation of vaccines for prevention and therapy of important pathologies
- Marc de la Roche, University of Cambridge, UK
Topic: Canonical and non-canonical targets in epithelial cancer
Preliminary programme
| Monday August 31st | ||
| 18:30 | Welcome party at Masaryk dormitory | |
| Tuesday September 1st | ||
| 9:00 | Intro | |
| 9:10 | L1 | Zdeněk Hostomský (IOCB Director, formerly Executive Director at Pfizer, La Jolla): Drug Discovery in Pharma and Academia: Same Goals, Different Routes |
| 10:10 | L2 | Stanislav Rádl (Zentiva Sanofi): Protein Kinase Inhibitors in the Context of Cancer Treatment |
| 11:10 | Break | |
| 11:20 | L3 | Radim Nencka (IOCB): Inhibitors of Phosphatidylinositol 4-kinases - Towards Broad-spectrum Antivirotics and New Tools for Chemical Biology |
| 12:20 | Lunch | |
| 13:30 | L4 | Pavlína Maloy Řezáčová (IOCB/IMG): Protein Crystallography in Drug Design |
| 14:30 | L5 | Václav Veverka (IOCB): Biomolecular NMR in Knowledge-based Drug Design |
| 15:30 | Break | |
| 15:40 | L6 | Lubomír Rulíšek (IOCB): A Good Servant, but a Bad Master - Is Computer Modeling a Useful Tool in Drug Discovery? |
| 16:20 | L7 | Daniel Svozil (UCT): Exploring Chemical Space for Drug Discovery |
| 17:00 | End of the session | |
| Wednesday September 2nd | ||
| 8:30 | L8 | Tomáš Ruml (UCT): HIV – Threat and Hope of Humankind |
| 9:30 | L9 | Richard Mackman (Gilead Sciences): Novel Virostatics |
| 10:30 | Break | |
| 10:50 | L10 | Kvido Stříšovský (IOCB): Thinking Out of the Box and Exploring the Unknown, a Role of Academic Research in Drug Discovery |
| 11:30 | L11 | Marc de la Roche (Univ. of Cambridge): Canonical and Non-Canonical Targets in Epithelial Cancer |
| 12:20 | L12 | Stephan Bachmann (LR AG): Catalysis as Key Technology for the Synthesis of APIs & Their Building Blocks |
| 13:30 | Lunch | |
| 14:30 | Guided Tour | |
| Beer Dinner | ||
| Thursday September 3rd | ||
| 9:00 | L13 | Markus Zettl (Boehringer Ingelheim): Biologics in Oncology |
| 10:00 | L14 | Peter Šebo (IMB): Next Generation Vaccines |
| 11:00 | Break | |
| 11:20 | L15 | Andrzej Marek Brzozowski (Univ. of York): Structural Endocrinology |
| 12:20 | Lunch | |
| 13:30 | L16 | Lenka Maletínská (IOCB): Food Intake Regulating Neuropeptides for Treatment of Metabolic Syndrome |
| 14:30 | L17 | Alena Zíková (Univ. of South Bohemia): Drug Discovery against Neglected Tropical Diseases |
| 15:30 | Break | |
| 15:40 | L18 | Karel Ulbrich (UMCH): Polymer - Drug Conjugates for Targeted Cancer Therapy |
| 16:40 | L19 | František Štěpánek (UCT): Remotely Controlled Release and in-situ Production of Pharmaceutically Active Substances Using Chemical Micro-Robots |
| 17:40 | End | |
| Friday September 4th | ||
| 9:00 | L20 | Jeroen van Bokhoven
(ETH Zurich, PSI Villigen, CH): EXAFS – a Powerful Tool for Exploring Materials |
| 10:00 | L21 | Werner Bonrath (DSM): New Trends of Heterogeneous Catalysis in Isoprenoid Chemistry |
| 11:00 | L22 | Igor Linhart (UCT): New Synthetic Drugs - from Cul de Sacs of Pharmaceutical Research to the Illicit Street Drugs |
| 12:00 | Closing remarks, lunch | |